Selected Transaction: M&A Buyer Representation

Biopool OrganonBiopool Xtrna

The Client

Biopool International Inc. ("Biopool") develops, manufactures and markets a full range of test kits to assess and diagnose disorders of blood coagulation, thrombotic risk factors, fibrinolysis, platelet function, and the vascular system, as well as specialty chemistry controls used to monitor and measure the presence of drugs of abuse. Biopool’s products are sold to hospitals as well as clinical and reference laboratories on a world-wide basis through an extensive network of distributors.

The Assignment

Context Capital Group ("Context Capital") was retained by Biopool to design and execute a growth through acquisition strategy, and was given a management role in executing this strategy. Biopool believed that retaining Context Capital would lead to a larger deal flow which would allow the Company to be selective in pursuing targets and determining value while not diverting the attention of management from the day-to-day operations of the Company. The growth through acquisition program designed by Context Capital encouraged a large group of acquisition professionals, brokers, finders, and investment bankers to bring ideas to Biopool. The outcome of this strategy was a constant review of possible transactions which identified targets at values considered very risky. With this market knowledge, Biopool targeted BGS which was thought to be an under-performer/castoff from Organon Teknika. Comprehensive due diligence and market knowledge uncovered an opportunity missed by most other companies reviewing BGS's operations.

Subsequent to this transaction, Price Paschall, Managing Director of Context Capital was asked to join the board of directors of Biopool.

In the second transaction, Context Capital was instrumental in the strategic repositioning of Biopool International. For years Biopool has produced a growing line of diagnostic products. Context Capital initiated Biopool's merger with Xtrana, an emerging genomics company, in order to accelerate the combined Company's growth prospects and enhance shareholder value.
Context Capital and Biopool are still actively reviewing and searching for additional acquisition candidates.

Scouted while visiting an Replica Handbags UK amusement park, Montero quickly garnered the attention of modeling’s star-makers. Casting director Ashley Brokaw has a long Swiss replica Watches history of launching distinctive models (stars like Replica Watches UK Aymeline Valade and Rolex Replica UK Sam Rollinson began their careers after being discovered by Brokaw) and she tapped Montero for a career-making exclusive at Prada Replica UK. Though Montero admits to not at first fully understanding the importance of walking Prada, once the day of the show arrived, it became clear. “It still feels like a dream—it was my first runway show. I can’t even describe it. I only thought before walking out, I can do anything since God gives me strength. After the show, so many people were congratulating me and saying I looked Replica Designer Handbags beautiful. It was really something I will never forget.”